سعر Farorecta 20 mg 4 f.c.tabs. 2026

Vardenafil 20 mg film-coated tablets (Pharopharma), pack of 4.

• Treatment of erectile dysfunction.Population: Adult menDailyMed (U.S. NLM)

• Most common (>=2%): headache, flushing, rhinitis/nasal congestion, dyspepsia, sinusitis, flu syndrome, dizziness, increased creatine kinase, nausea and back pain.International label, same formulation · DailyMed (U.S. NLM)

• Contraindicated with nitrates or nitric oxide donors in any form, and with guanylate cyclase stimulators such as riociguat (risk of severe hypotension).International label, same formulation · DailyMed (U.S. NLM)

• Evaluate cardiovascular status before use (sexual activity carries cardiac risk); seek emergency care for erections lasting more than 4 hours (priapism); stop and seek care for sudden loss of vision (NAION) or sudden decrease/loss of hearing; may prolong the QT interval - avoid in congenital QT prolongation and with class IA or III antiarrhythmics.International label, same formulation · DailyMed (U.S. NLM)

• Nitrates / nitric oxide donorsContraindicated: potentiates the hypotensive effect of nitrates.DailyMed (U.S. NLM)
• Strong/moderate CYP3A4 inhibitorsRitonavir or cobicistat: do not exceed 2.5 mg in 72 hours; indinavir, saquinavir, atazanavir, clarithromycin, ketoconazole/itraconazole 400 mg daily: max 2.5 mg in 24 hours; ketoconazole/itraconazole 200 mg daily or erythromycin: max 5 mg in 24 hours.DailyMed (U.S. NLM)
• Alpha-blockersPatients should be stable on alpha-blocker therapy before starting; start vardenafil at 5 mg (risk of symptomatic hypotension).DailyMed (U.S. NLM)

• Not indicated for use in females.International label, same formulation · DailyMed (U.S. NLM)

• Vardenafil: Selective PDE5 inhibitor that enhances the nitric oxide/cGMP pathway during sexual stimulation (US vardenafil label).